Jacob E John
AeroLeads people directory · profile

Jacob E John Email & Phone Number

Co-Founder at Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases
Location: Germany 22 work roles 5 schools
LinkedIn matched
✓ Verified July 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases
Role
Co-Founder
Location
Germany

Who is Jacob E John? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jacob E John is listed as Co-Founder at Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases, based in Germany. AeroLeads shows a matched LinkedIn profile for Jacob E John.

Jacob E John previously worked as Co-Founder at Infectious Diseases Societies and Co-Founder, Process-Owner, Biologist and Scientist at Research And Development For Rare Diseases (With Fda, Ema, Ich, Ddc). Jacob E John holds Bachelor Of Science (Bs), Diplom (M Sc), Dr Rer Nat (Ph D), Dr Of Science (Biology), Biology from Heidelberg University.

Profile bio

About Jacob E John

We know persons, whose friends have been affected by rare diseases or tropical diseases.Thinking about how the quality of medicines, vaccines, diagnostics and medical devices for rare diseases and tropical diseases will be ensured and managed.All medicines, vaccines, diagnostics and medical devices must receive approval from the FDA (USA), EMA (Europe), ICH (Intl Conf Harmonization), Directorate of Drugs Control DDC (Asia, Africa, South & Central America, Oceania), which is essential for the approval of medicines and patients' safety.All production processes for medicines, vaccines, diagnostics and medical devices must conform with the best standards and practices for ensuring and maintaining "Health, Safety and Environment"​. All distribution processes for medicines, vaccines, diagnostics and medical devices must conform with the best standards and practices for ensuring and maintaining "Health, Safety and Environment"​. PreClinical Research, Pharma, BiotechBiologist, 25+ years research experience BiologyBiochemistry MicrobiologyCell BiologyPharmacology Medicinal Chemistry Cancer Infectious Diseases Tropical Diseases Rare DiseasesNatural productsProject / Line-Function ManagementSpecialties: strategic thinking and planning (research, drug discovery, diagnostics, vaccines)(humanistic) psychology for managers and team buildingEconomics (a simple version) related to Research and Development. Production and Distribution. Health Care, Hospitals & Clinics, in low-resource-regions. Jacob E John, Medicines for tropical diseases; support through tax-incentives, Drug Discovery Today, 2010 2011, 16 (3/4), 91–92. with FDA, EMA, DDC.Cost to the economy = + 0.5% for energy. i.e. from 100 currency units to 100 and 1/2 currency units. About 0.05% of GDP. Asia, Africa, South & Central America ......... Europe, North America.This covers research and development, production and distribution.Medicines, vaccines, diagnostics and medical devices.

Current workplace

Jacob E John's current company

Company context helps verify the profile and gives searchers a useful next step.

Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases
Study Groups For Rare Diseases, Tropical Diseases And Veterinary Diseases
Co-Founder
22 roles · 42 years

Jacob E John work experience

A career timeline built from the work history available for this profile.

Co-Founder

Current
Study Groups For Rare Diseases, Tropical Diseases And Veterinary Diseases

It may be enquired and proposed, whether the "country" pharma/biotech drug manufacturers associations in each country, will set up Study Groups for rare diseases, medicines, vaccines, diagnostics and medical devices, on a long term basis.11 Univ Prof. physicians (medicine) 7, and scientists 4. 11 Pharma, Biotech, physicians 7, and scientists 4. 22 members.Annual Conferences. Annual Perspectives. Annual Reviews. It may be enquired and proposed, whether the "country" pharma/biotech drug manufacturers associations in each country, will set up Study Groups for tropical diseases, veterinary diseases, medicines, vaccines, diagnostics and medical devices, on a long term basis.11 Univ Prof. physicians (medicine) 5, scientists 4, and veterinarians 2. 11 Pharma, Biotech, physicians 5, scientists 4, and veterinarians 2. 22 members.Annual Conferences. Annual Perspectives. Annual Reviews.Study Groups11 members nominated by Country Medical Associations 9, University Medical Schools 1, WHO 1. 11 members nominated by Country Drug Manufacturers Associations.Formation and Nominations, every two yearsGender EqualTwo year term Open Access Articles, Medical JournalsNine to eleven meetings each year Meetings, one weekBoard & Lodging, 4* HotelCompensation, Univ ProfessorPermanent Secretariat at ........, 2 physicians, 2 scientists, 2 executive assistants, 2 managers.

May 2013 - Present

Co-Founder

Infectious Diseases Societies

Asia Africa South America Central America Oceania

Infectious Diseases Society of Asia. Conferences, Study Groups, Courses and Workshops, and Journals.Infectious Diseases Society of Africa. Conferences, Study Groups, Courses and Workshops, and Journals.Infectious Diseases Society of South & Central America. Conferences, Study Groups, Courses and Workshops, and Journals.Infectious Diseases Society of Oceania. Conferences, Study Groups, Courses and Workshops, and Journals.Membership-based organizations, 11+ co-chairpersons, gender equal, Science and Medicine. International, annual conferences on tropical diseases, veterinary diseases and infectious diseases.Publications of conference proceedings, by Infectious Diseases Society.Major tropical diseases, above 22+Minor tropical diseases, above 111+Veterinary infectious diseases, above 55+

Co-Founder, Process-Owner, Biologist And Scientist

Research And Development For Rare Diseases (With Fda, Ema, Ich, Ddc)

Thank you for your support, Universities, Scientific and Medical Societies, and Schools of EconomicsJacob E John, Medicines for rare diseases; support through tax-incentives, Drug Disc Today, 2011, Dec, 16 (23/24), 999-1000. ..... with FDA, EMA, DDC above 5252 rare diseases.including rare types of cancer, cardiac conditions, thoracic conditions, respiratory conditions, ophthalmic conditions, vascular conditions, epithelial conditions, skin conditions, muscle-skeletal conditions, digestive conditions, infections, neurological conditions, inflammation, immunological conditions, endocrine conditions, connective tissue conditions, exocrine conditions, metabolic conditions, ear conditions (hearing, balance), dental conditionsMedicines, vaccines, diagnostics and medical devicesDedication; Declaration of Geneva for Medicine. Dedication; Mothers' Day, Fathers' Day & Children's Day .A key for ~ 10,000+ jobs in Europe, USA, Canada, Japan, ANZ, and Asia, Africa, and South & Central AmericaEmployee Ownership of Organisation = 15%Cost to the economy = + 0.5% for energy. about 0.05% of GDPAbout 25+ billion US$ p. a., across North America, Europe, ANZ, and Asia, Africa, and South & Central AmericaThis covers research and development ...... and production and distributionCompliant with SDG MDG ILO WTO FDA EMA ICH DDC IP Liberty Trust HealthCare Equality Justice Law Sovereignty, Fraternity of People and Nations, Goodwill, Peace, not-for-loss, CSR multi-lateral.NOT Included: MP Innovation, IMI, Venture Captl.

Information

Rare Diseases, Tropical Diseases, Veterinary Diseases.

For Pharmaceutical Companies And Biotechnology Companies

Medicines research for rare diseases, support through tax-incentives.Research and development, production and distribution of medicines, vaccines, diagnostics and medical devices for rare diseases.Jacob E John, Medicines for rare diseases; support through tax-incentives, Drug Discovery Today, 2011, 16 (23/24), 999-1000. ..... with FDA, EMA, DDC.These two areas are linked for large Pharma and Biotech Co's (MNC)Medicines research for tropical diseases, support through tax-incentives.Research and development, production and distribution of medicines, vaccines, diagnostics and medical devices for tropical diseases and veterinary diseases.Jacob E John, Medicines for tropical diseases; support through tax-incentives, Drug Discovery Today, 2010 2011, 16 (3/4), 91–92. .... with FDA, EMA, DDC.in Asia, Africa, South & Central America, Pacific Ocean regions.This area "Tropical Diseases"​ is essential for Pharma and Biotech Co's in Asia, Africa, South & Central America and Oceania.Compliant with SDG MDG ILO WTO FDA EMA ICH DDC IP Liberty Trust HealthCare Equality Justice Law Sovereignty, Fraternity of People and Nations, Goodwill, Peace not-for-loss CSR multi-lateral.For Pharmaceutical Companies and Biotechnology Companies, only.In-house pre-clinical Research and clinical Development.Employee Ownership of Organisation = 15%Mutually beneficial arrangements with Universities, Academia and public-funded research organizations will cover pre-clinical research, clinical development, and clinical and medical use.Just Thinking about Quality.Not included: London Declaration on NTDs 2012. United to Combat NTDs. Kigali Declaration on NTDs 2022.Adverse effects of medicines. Drug-resistance (AMR). Deficient in pre-clinical and clinical R&D. Disease areas, limited range.Vaccines, Diagnostics, Medical Devices not mentioned.Limited Participation. Not Inclusive.Developmental Economics ?Scientific, Medical Literature ?Location ? Conferences ?

Senior Scientist

Tropical Infectious Diseases

Natural products, Biotechnology and Drug DiscoveryJacob E John, Natural products-based drug discovery: some bottlenecks and considerations, 2009, Current Science, 25th March, vol 96(6), 753-754.Jacob E John, Natural products as lead-structures; a role for biotechnology, 2010, Drug Discovery Today, Volume 15, Issues 11-12, June 2010, Pages 409-410.

Founder, Process-Owner, Biologist And Scientist.

Research And Development For Tropical Diseases, Veterinary Diseases (With Ich Fda Ema Ddc)

Thank you for support, Universities, Scientific and Medical Societies, and Schools of Economics.Developing the scope and success for tropical diseases research, in tandem with several other research areas, e.g. cancer, natural products, (published in 2009, 2010).Drug Discovery Research, Tropical Diseases.Malaria Leishmaniasis Chagas Filariasis TB viral infections fungal infections HAT (sleeping sickness).Biology Lead discovery Project management.focused libraries, natural product-like compounds, cell-based screening.JE John, Medicines for tropical diseases; support through tax-incentives, Drug Discovery Today, 2010 2011, volume 16 (3/4), 91–92. with FDA EMA DDCDedication; Declaration of Geneva for MedicineMedicines, vaccines, diagnostics and medical devices.all tropical diseases Approx ~ 8,000+ jobs in Asia Africa, South & Central America, Europe (Greece Cyprus Malta Spain Portugal Italy) North America (Hawaii Honolulu), Oceania ANZ European colonies (Caribbean Atlantic Pacific Indian Ocean)Cost to economy = + 0.5% for energy. about 0.05% of GDPAbout 5+ billion US$ p.a. Asia Africa, South & Central America ......... Europe, North AmericaCompliant with SDG MDG ILO WTO FDA ICH EMA DDC IP Liberty Trust HealthCare Equality Justice Law Sovereignty Fraternity of Nations Goodwill Peace no loss CSRJE John, Tropical diseases research and anti-fungal research linked with cancer research, Current Science, 2009, 97(12), 1704. with FDA EMA DDCJE John, Anti-infective agents; natural products based drug discovery, Current Science, 2007, 93(10), 1336-1337. (cf co-enzymes, nucleotides).JE John, Natural products-based drugs and membrane permeability, A hypothesis, Chem Biol Drug Design, 2009, 73, 367-368.JE John, Cytotoxic natural products and their pharmacological mode of action; a hypothesis on their complexity and spectrum of activity. Current Enzyme Inhibition, 2012, 8 (1), 101-103.Employee Ownership of Organisation = 15%

Founder, Process-Owner, Biologist And Scientist

Research And Development For Tropical Diseases, Medicines, Vaccines, Diagnostics (Fda, Ema, Ddc)

Thank you for your support, Universities, Scientific and Medical Societies, and Schools of Economics.R&D for Tropical Diseases, medicines, diagnostics and vaccines, public funding, above 5 countries. "Network"​, driven by science. more than 22+ indications. R&D for Tropical Diseases, Drug Discovery, public funding, above 5 countries. Natural products research. "Network"​, driven by science and patents. "Collaborations with pharma and biotech companies ...with tax-incentives ... FDA EMA."​in Asia, Africa, and South & Central America.Jacob E John, Natural products-based drug discovery: some bottlenecks and considerations, 2009, Current Science, 25th March, vol 96(6), 753-754.JE John, Pharma Research for Tropical Diseases, Current Science, 2006, 91(9), 1127, Bangalore (Indian Academy of Sciences), India. Dedication; Declaration of Geneva for Medicine.A key for ~ 5000 jobs in India, Pakistan, Turkey, China, S Africa, Brazil, Argentina, Mexico, ......... "Network", driven by science and unmet medical needs. Cost to the economy = + 1% or 2% for medicines, vaccines, diagnostics.Compliant with MDG SDG ILO WTO IP Liberty Trust HealthCare Equality Justice Law Sovereignty, Fraternity of People and Nations, Goodwill, Peace not-for-loss, CSR multi-lateral. JE John, Anti-Infective Agents: Spectrum and Selectivity, Current Science, 2007, 92(2), 159, Bangalore (Indian Academy of Sciences), India.

Tropical Diseases R&D

Information

JE John, Medicines for tropical diseases; support through tax-incentives, Drug Discovery Today, 2011 (2010), volume 16 (3/4), 91–92. ..... with FDA and EMA.JE John, Tropical diseases research and anti-fungal research linked with cancer research, Current Science, 2009, 25th Dec, 97(12), 1704. with FDA and EMA.JE John, Pharma Research for Tropical Diseases, Current Science, 2006, 91(9), 1127, 2006, Bangalore (Indian Academy of Sciences), India.Peace is always welcomeWhom It May ConcernInformationOrganizations that are NOT included in these frameworks for tropical diseases research and development for medicines, vaccines and diagnostics.CRO, WEF (Bilderberg), BMGF & similar foundations, WB, IMF, Wellcome Trust, WHO-TDR, ANDI, ..NDI, UNOPS, WHO-NTD, G7, MMV, TB Alliance, DNDi, FIND, AREAS, GAVI, IAVI, MM4TB, NM4TB, iM4TB, PATH, OSDD (CSIR), GHIT, Global Fund GFATM, unitaid, UNAIDS, DFID, USAID, UKAID, "Country-AID"​, CHAI, EU-EC, NIH, Global Research Council, Universities, "StopTb"​, MSF, WRAIR, IDRI, GAFFI, MPP, WWARN, IDDO, Sabin, EVI, IVI, VIDO, The Union TB, FDA-Vouchers, KNCVTBC, DDTD, Malaria Consortium, MalariaNoMore, EDCTP, EastWestScienc, eghstrat, csgid, thesgc, TBVI, Broad Inst, FNDR, MP-Innovation, EVT, ASTX, Venture Captl, GARDP, GHDDI (Beijing), ospfound.not included: London Declaration on NTDs 2012.United to Combat NTDs.Kigali Declaration on NTDs 2022.Adverse effects of medicines. Drug resistance (AMR). Deficient in pre-clinical and clinical R&D deficient. Disease areas, limited range.Vaccines, Diagnostics, Medical Devices not mentioned.Limited Participation. Not Inclusive.Developmental Economics ?Scientific, Medical Literature ?Location ? Conferences ?

Observer And Scientist

I P Regime And W T O

Intellectual Property Intellectual Property protection, for patents, trademarks, geographical indications and copyrights, introduced in Asia, Africa and South America. In compliance with World Trade Organisation.IPR and Research & Development.(Prior intl discussions in 2000).

Research Scholar

Developmental Economics, Ecological Economics

Scientist And Observer

Ecological Economics, Sustainable Development and Carbon Credits (Common Good)Forests provide several environmental services, through carbon sequestration (carbon credits), oxygen generation, water & soil conservation, and flood control. Oceans also.When carbon taxes are paid and carbon credits are earned, this is a huge amount, when scaled over a whole region, years and decade(s)This serves to benefit sustainable development in all areas, including healthcare, education, public transport, joint ventures, 17SDG 3R Renewables, forestry, agriculture, environment/conservation, MSME, (public debt),The total annual financial trade in carbon credits is estimated to be in the range of 400 billion US$ (equivalent) world wide, annually, for the year 2022. Of this amount some estimates suggest80 billion US$ (equivalent), South America50 billion US$ (equivalent), sub-Saharan Africa20 billion US$ (equivalent), South Asia50 billion US$ (equivalent), South East Asia10 billion US$ (equivalent), Europe40 billion US$, North America30 billion US$ (equivalent), China50+ billion US$ (equivalent), Russia5/10 billion (US$ equivalent), central Asia15/25 billion (US$ equivalent), Australia & New ZealandOceans IslandsAnnual estimates for carbon credits for the previous decades are similar, and less than these current estimatesReference year for omitted and due payments, 1950 (UNO)World leaders, Scandinavian countries (1970)As multi-lateral, multi-country and multiple, intercontinental frameworks, worldwide, the peace dividends are enormous in time and scale (SDG)c/o SDG UNEP UNDP FAO UNFF UNICEF UNFCCC UNIDO IPCC WMO WHO UNWomen UNESCO ILO UNOCHA UNHCR WFP UNDRR EEA UNSDSN, regional and intl development banks, i.e. Asian Development Bank, African Development Bank, World Bank IADB NDB GCF, annual conferences, all regions, areas and subjects, (not WEF)If you want to go far, go together If you want to go fast, go aloneLeave none behindAfrican Wisdom

Adj Professor, Biology

Drug Discovery Research for Tropical Diseases.Malaria, Leishmaniasis.Biology, Lead discovery, Project management.focused libraries, natural product-like compounds, cell-based screening.

Apr 2010 - Jun 2024

Scientific Observations

Environment And Sustainability

Biofuels, Transport And Carbon Cycles

BioFuels, Transport and Carbon CyclesCarbon CyclesCarbon Emissions of Surface-Transport and Conversion by photosynthesis in Forests, Farms and Oceans.Time scale is 1 to 2 weeks (summer) or 3 to 4 weeks (winter).Altitude is below 500m above ground level.Respiration in Forests and Farms and Photosynthesis.Time scale is one day or 24 hrs.Altitude is below 100m above ground level, (e.g. redwoods and baobab trees)Bio-Diesel is lamp oil (18th century)Bio-Ethanol is whisky science (before 18th century)Low energy quotient (output / input)Ground Level. $$?Keeling Curve measurements; Mauna Loa Observatory Hawaii, 3397mslCommentsCritical reviews are overdue, and are not to be seen anywhere, (ref UNEP).No real benefits for small "Island States" and sea level rise (2100 CE).c/o UNEP, UNDP, UNICEF, UNESCO, WMO, GCP, FAO, WFP, IOM, ILO, UNIDO, ICJ, UNHRC, UNODA, EEA, EUREC, LSE, BGCI, UNSDSN, EPA, WHRC (MA, USA), EarthDay, DAI (USA), TWAS, ISC, CIPSH, IPU, UNGA, UNSC, WB, IADB, CDB, EBRD, AfDB, ADB, NDB, WTO, REN21, IRENA, IPB, IFEU, SEI (SE), ICRC, Pugwash, IFS, Grameen, GBM, IUCN, WWF, CGIAR, CIFOR, ICRISAT, Trees for the Future, TERI, ATREE, DevAlt, CSE, CES (IISc), et al(not WEF, Bilderberg)intellectual level, unclassified.

Dec 2004 - Jun 2015

Guest Editor

Current Enzyme Inhibition

Bentham Science Publications

Tropical Diseases, Malaria, Tuberculosis, Natural Products

Jan 2011 - Apr 2014

Rare Diseases

Medicines Vaccines Diagnostics And Medical Devices

Europe, North America, South & Central America, Africa, Asia And Oceania.

Rare DiseasesMedicines, Vaccines, Diagnostics and Medical Devices.Research and Development, Production and Distribution.Reviews completed.

Jun 2011 - Dec 2012

Guest Editor

Anti-Infective Agents

Bentham Science Publications

Tropical Diseases, Malaria, Tuberculosis, Natural Products

Jan 2011 - Dec 2012

Tropical Diseases

Medicines Vaccines Diagnostics And Medical Devices

Asia, Africa, South & Central America, Oceania, Europe And North America

Tropical DiseasesMedicines, Vaccines, Diagnostics and Medical Devices.Research and Development, Production and Distribution.no loss. Reviews completed 2005 to 2012.

Jul 2005 - Dec 2012

Senior Research Scientist, Biology

in vitro Biology Biochemical Screening in vitro ADMENP like compounds

2002 - 2004 ~2 yrs

Senior Research Scientist, Biology

Infectious diseases Lead discoveryBiology.

Jan 2000 - Apr 2001

Research Scientist, Biology

Tropical diseasesMalaria Tuberculosis Lead discovery BiologyProject Leader, Research Team Leader

1995 - 2000 ~5 yrs

Scientist, Biology

Heidelberg Area, Germany

Program of Biological Structures. Dr Dimitrius Tsernoglou.Protein Folding in the CellMolecular chaperones of bacteria (E coli) Structure-function relationship.protein crystallography (6 Angstrom, unpublished)GroEL (nucleotides, peptides), apo-protein and 3 liganded statesSecA (nucleotides, peptides), apo-protein and 3 liganded statesSecB (peptides), apo-protein and 1 liganded stateATP hydrolysis and the local energy minimum in protein-folding, GroEL/GroES, DnaK.Model peptides of L-AAs (leader sequence) and D-AAs (Melittin).No stereo-specificity or selectivity in peptide binding and ATP hydrolysis. No energy transduction of ATP hydrolysis and the local energy minimum in protein-folding (unpublished, GroEL/GroES, DnaK).Protein Folding in the CellCollaborations:Peptide Synthesis Dr Mathias Mann, EMBL Heidelberg, Heidelberg, Germany.GroEL/GroES Dr Costa Georgopoulos, Dept of Biochemistry, University Utah, University GenevaGroEL/GroES 2D crystals and electron microscopy. Dr K Lennard, EMBL, Heidelberg.DnaK/DnaJ/GrpE Dr Costa Georgopoulos, Dept of Biochemistry, University Utah, University GenevaSecA Dr Shoji Mizushima, Inst of Microbiology, University Tokyo, JapanSecB Dr P J Bassford, Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, USASRP48/FtsY Dr B Dobberstein, EMBL-Heidelberg, Heidelberg, Germany.ATP phosphorothioate analogs Dr F Eckstein, MPI Exptl Medicine, Dept of Chemistry, Goettingen, Germany.? Molecular chaperones of Mitochondria, Fungi, Parasites ?Infectious Diseases, Tropical DiseasesEMBL’s European Bioinformatics Institute (EMBL-EBI), Hinxton, UK(AdenoViruses, L Philipson, DG) (Semliki Forest Virus, S Fuller, Program of Biological Structures) (Trypanosome brucei, surface antigens, P Metcalfe, Program of Biological Structures)(Bacterial Elongation Factors, R Leberman, S Cusack, EMBL Grenoble)(Bacterial Toxins, Colicin, Aerloysin, F Pattus)

1990 - 1993 ~3 yrs

Intl Conferences Tropical Diseases

Who Tdr

Read the Conference Reports and Proceedings1988 Thailand1992 Florida? .... 1996, 2000, 2004, 2008, 2012, 2016, 2020, 2024 .... ?

1988 - 1992 ~4 yrs

Msc Phd Scientist, Biology

Max Planck Insititute For Medical Research

Heidelberg, Germany

Dept Biophysics. Prof Dr K C Holmes et al.,G-proteins and cancer Structure-function relationshipsMutations and OncogenesisOther activities:(BetriebsRat) Works Council, Health, Safety and Environment

1985 - 1989 ~4 yrs
5 education records

Jacob E John education

Bachelor Of Science (Bs), Diplom (M Sc), Dr Rer Nat (Ph D), Dr Of Science (Biology), Biology

Activities and Societies: Biological Chemistry, Molecular Biology, Cell Biology, Biophysics, Organic Chemistry, Environmental Sciences,

A Levels, Biology Chemistry Mathematics

Hebron School Ootacamund (Nilgiris)

Activities and Societies: sports and music

Std 12, Indian School Certificate, Biology, Chemistry, Physics, Mathematics, English, Hindi, German

Activities and Societies: sports music debating

Std 10. Indian Certificate Of Secondary Education, Biology, Chemistry, English, Geography, Hindi, History, Physics, Religion & Philosophy.

Clarence High School Bangalore

Activities and Societies: sports, debating, music, theater,

FAQ

Frequently asked questions about Jacob E John

Quick answers generated from the profile data available on this page.

What company does Jacob E John work for?

Jacob E John works for Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases.

What is Jacob E John's role at Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases?

Jacob E John is listed as Co-Founder at Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases.

Where is Jacob E John based?

Jacob E John is based in Germany while working with Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases.

What companies has Jacob E John worked for?

Jacob E John has worked for Study Groups For Rare Diseases, Tropical Diseases And Veterinary Diseases, Infectious Diseases Societies, Research And Development For Rare Diseases (With Fda, Ema, Ich, Ddc), Rare Diseases, Tropical Diseases, Veterinary Diseases., and Tropical Infectious Diseases.

How can I contact Jacob E John?

You can use AeroLeads to view verified contact signals for Jacob E John at Study Groups for Rare Diseases, Tropical Diseases and Veterinary Diseases, including work email, phone, and LinkedIn data when available.

What schools did Jacob E John attend?

Jacob E John holds Bachelor Of Science (Bs), Diplom (M Sc), Dr Rer Nat (Ph D), Dr Of Science (Biology), Biology from Heidelberg University.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Jacob E John you were looking for.

View similar profiles